key: cord-0783828-89umeagd
authors: Gallo, Antonella; Pero, Erika; Pellegrino, Simona; Macerola, Noemi; Murace, Celeste Ambra; Ibba, Francesca; Agnitelli, Maria Chiara; Landi, Francesco; Montalto, Massimo
title: How can biology of ageing explain the severity of COVID-19 in older adults
date: 2022-04-22
journal: Clin Geriatr Med
DOI: 10.1016/j.cger.2022.04.002
sha: 50bb4846f5165a1527ff3280487cd6886df7b028
doc_id: 783828
cord_uid: 89umeagd

Aging has been identified as one of the most relevant risk factor for poor outcomes in COVID-19 infection. Since now, different mechanisms responsible for worse outcomes in the elderly have been proposed. They include the remodeling of immune system, the higher prevalence of malnutrition and sarcopenia, the increased burden of multimorbidity and, to a lesser extent, the direct effects of age on the respiratory system and hormonal profile. It seems that the interplay between all these causes, rather than the individual pathophysiological mechanism, explains the increased severity of the disease with age.

or no pneumonia (81% of cases) to severe pneumonia (14% of cases) and critical pneumonia (5% of cases) 5, 6 .

Aging has been identified as one of the most relevant risk factor for poor outcomes in COVID-19 disease, independently from the presence of pre-exiting diseases [7] [8] . The COVID-19 mortality risk sharply increases for elderly subjects, as showed by the reports of China, Italy and US 7 . In particular, in Italy, case fatality rate for patient aged 40-49 years or younger was reported of about 0.4% or lower, 1% among those aged 50-59 years, 3.5% in those aged 60-69 years, 12.8% in those aged 70-79 years, to 20.2% from 80 years and above 8 .

Age is not only an important predictor for mortality, but it is also associated with higher disease severity, in terms of increased hospitalization rates, length of hospital stay, need for intensive care and invasive mechanical ventilation (IMV) [8] [9] [10] [11] . Since now, different mechanisms responsible for worse outcomes in the elderly have been suggested [12] [13] [14] . They include the remodeling of immune system, the higher prevalence of malnutrition and sarcopenia, the increased burden of The interplay between all these causes, rather than the individual pathophysiological mechanism, explains the J o u r n a l P r e -p r o o f increased severity of the disease with age. multimorbidity and, to a lesser extent, the direct effects of age on the respiratory system and hormonal profile [8] [9] [10] [11] [12] [13] [14] .

The terms "immunosenesce" and "inflammaging" refer to age-related physiologic changes in both innate and adaptive immune system, that lead to a higher incidence of infection, cancer, and autoimmune disease in the elderly population 15 .

The decline of the immune system with age, consisting of inappropriately amplified and dysregulated immune responses 15 , leads not only to a greater susceptibility to bacterial and viral infections but also to more severe consequences of infectious disease, such as severe respiratory failure in COVID-19 infection, and lowered responses to vaccination [15] [16] . Interestingly, age-related remodeling of the immune system is associated with a sort of paradox: a state of increased autoimmunity and inflammation coexistent with a state of immunodeficiency 16 .

"Immunosenesce" represents the gradual deterioration of the host's ability to mount an effective immune response against new antigens, while "inflammaging" identifies a state of chronic, sterile low-grade inflammation resulting from the long-term physiological stimulation of an overactive, yet ineffective, immune system. Together, these two mechanisms might facilitate the development of cytokine storm in elderly 16 .

Aging strongly affects the immune system, influencing both the humoral and cellular arm of immunity, from hematopoietic stem cells to mature lymphocytes in secondary lymphoid organs.

Since now, several hallmarks of immunosenescence have been identified. One of the salient features of this mechanism is the decrease in peripheral naïve T cell 17, 18 , as a result of the fibroadipose involution of the thymus and the reduced ability of lymph nodes to store, maintain and support naïve J o u r n a l P r e -p r o o f T cells with age. Although there is a 95% reduction in the number of naive T lymphocytes in the elderly compared to young people 19 , there is only a slight reduction in the total number of T lymphocytes in advanced age 19, 20 . This is due to the compensatory accumulation of memory T cells 19 .

These senescent cells are mainly characterized by a decrease in T cell receptor (TCR) repertoire 21 and by a reduction in the expression of the costimulatory surface protein CD28+, which is the signature of replicative senescence 22 . Indeed, CD28 is not only important in lymphocyte activation but also plays a role in telomere homeostasis 23 . Memory cells are characterized by low telomerase activity, high production of Reactive Oxygen Species (ROS) and constitutive activation of p38 mitogen-activated protein (MAP) kinase, which once activated, blocks signaling via TCRs 24 . All these changes contribute to the decreased ability of the aging immune system to mount an adaptive response against new antigens.

"Immunosenescence" is also characterized by the imbalance of the Th1/Th2 ratio 25 . The host's ability to balance the differentiation of CD4 lymphocytes into Th1 phenotypes, which has a proinflammatory role, and Th2 which has an anti-inflammatory function, is vital for the neutralization of pathogens without inducing damages to host tissues 25, 26 . It seems that in elderly patient there is an impairment in this mechanism that would favor the development of more severe forms of COVID-19 disease 25 . Indeed, in early stage of the infection there is a predominant Th2 response, that would aid viral replication, followed by a rapid upregulation of Th1 response that would lead to cytokine storm and development of critical illness 25, 27 . On the same note, in the elderly population there is an upregulation of the pro-inflammatory pathways mediated by Th17 cells and a loss of the antiinflammatory response mediated by Treg lymphocytes 28 .

Moreover, a reduction in CD8+ T cells has also been described in severe cases of COVID-19 29 , suggesting an impairment of the host's ability to fight viruses. The functional exhaustion of the cytotoxic function of CD8+ due to the reduction of the co-expression of perforin and granzyme B 30 , has already been associated not only with an increased risk of contracting influenza infection but also with increased disease severity in elderly 31,32 . J o u r n a l P r e -p r o o f As regarding humoral immunity, older people showed both a decrease in bone marrow output of naïve B-lymphocytes 33 and the accumulation of the double negative (DN) B cells subtype, that are exhausted cells with functional impairment 34, 35 . The accumulation of these dysfunctional B-cells has been reported in healthy elderly subjects and recently in severe cases of COVID-19 disease 36 .

As a result of the decline of both T and B lymphocytes, aged individuals are characterized by an ineffective antibody response, in terms of decreased affinity, poor neutralization of antigens and production of antibodies more prone to autoreactivity 35 . Moreover, for the same reasons, the duration of protection of immunity following vaccination is usually shortened in this population 37 .

Finally, the mechanism related to the "antibody dependent enhancement (ADE)" has also been associated with severity of COVID-19 infection 38 . ADE is a phenomenon whereby the binding of virus to non-neutralizing antibodies, produced during other infections, promotes its internalization into host cells and facilitates the downstream inflammatory responses 39 . This mechanism has been described for other coronavirus infections, such as Sars-CoV1 and Mers 40, 41 , as well as for other viral infections (i.e. Dengue fever and HIV) 39 . It has been suggested that elderly might be more prone to these mechanism because of the exposition of a lifetime to circulating virus 13 .

Older patients may show a baseline low-grade inflammation in the absence of infectious processes 42 .

This condition, called "inflammaging", is characterized by high baseline serum concentration of C reactive protein and cytokines (IL-6 and IL-8) and is associated with increased fragility and morbidity 42 . Inflammaging may be the result of multiple mechanisms, including the accumulation of misfolded proteins, the gut barrier leaking and obesity 43 . Moreover, elderly may be characterized by an impaired clearance of dead and dying cells from sites of immune activity 42 , leading to persistent inflammation, and by the presence of senescent cells, that do not proliferate but secrete inflammatory molecules (process known as the senescence-associated secretory phenotype, SASP) 22 . This excessive inflammation can negatively impact some functions of the immune system 42 Severity of COVID-19 disease has also been correlated to the neutrophil-lymphocyte ratio (NLR), usually indicative of low grade inflammation in elderly, as in obesity, metabolic syndrome and diabetes 44 .

Several epidemiological studies reported that the presence of pre-existing comorbidities represents a relevant risk factor in COVID-19 patients for a more severe disease in terms of increased and prolonged hospitalizations, and mortality [45] [46] [47] [48] [49] [50] [51] .

The most common comorbidities found in COVID-19 patients' cohorts were diabetes, hypertension, obesity, chronic cardiovascular, pulmonary and kidney diseases [45] [46] [47] [48] [49] [50] [51] [52] . These are all medical conditions characterized by a state of chronic inflammation associated with a weakened immune response that could explain the predisposition to infections and disease complications.

Although there are many studies investigating the role of comorbidities in COVID-19 disease in the general population, there are not many data addressing the association between comorbidities and aging. A Spanish retrospective study including 834 patients aged 60 years and older, hospitalized for COVID19, showed that patients with heart failure and chronic kidney disease had an increased risk of hospital mortality 52 Instead, significant differences were found across age subgroups for other chronic conditions and their association with mortality. In particular, in subject aged 70-90 years, congestive heart failure and dementia were significantly associated with higher risk of mortality 54 .

Relevant data on impact of comorbidities in older COVID-19 patients also derive from studies on skilled nursing facilities where, mainly during the first outbreak, a rapid virus transmission between residents was reported 55 . In a context of a US nursing facility, during the rapidly escalating COVID-19 outbreak in March 2020, McMichael et al. found a death percentage of 33.7% for residents, in respect to 6.2% for visitors and 0% for staff. Residents showed a medium age of 83 years old, most of them having one or more co-morbidities, such as hypertension (67%), chronic cardiac disease (60%), kidney disease (41%), diabetes (32%) 55 .

The postulated mechanisms for a worse prognosis in these co-morbid and older patients mainly include the dysregulation of the immune system associated with chronic low-grade inflammation favoring cytokine storm, the pro-thrombotic state and endothelial dysfunction with consequent increased risk of thromboembolic events, the dysregulated and widespread angiotensin enzyme 2 (ACE2) activity promoting viral uptake, as better described in the following paragraphs.

Diabetes represents one of the commonest comorbidities, whose prevalence in COVID-19 patients ranges from 7.3% in China 5 to more than 30% in Europe 56 . Diabetes does not seem to increase the incidence of Sars-Cov2 infection 57, 58 , but it can unfavorably modify the course of the disease, with an increased risk of disease progression, with development of acute respiratory distress syndrome and multi-organ failure and higher mortality rate 59 . Moreover, retrospective studies showed that COVID-19 patients with diabetes had higher levels of inflammatory biomarkers (such as neutrophil-tolymphocyte ratio, high-sensitivity C reaction protein, and procalcitonin) when compared to nondiabetes patients [60] [61] [62] . Therefore, diabetes has been recognized as an independent risk factors for poor J o u r n a l P r e -p r o o f prognosis in COVID-19 patients. However, when stratifying diabetic subjects to identify those at higher risk of death, Schlesinger et al. showed in their meta-analysis that older age (>65 years) was significantly associated with higher risk of COVID-19 associated death and with COVID-19 severity 63 . Reasons for higher COVID-19 complications in this subgroup of diabetics were mainly related to glycaemic instability and association with pre-exiting comorbidities, such as hypertension, cardiovascular and kidney disease, together with the suggested influence of a chronic low-grade inflammation and factors associated with viral entry (like ACE2 expression) [60] [61] [62] [63] .

A sufficient protein intake and a good nutritional status are required for an optimal antibody production and for the synthesis of acute-phase proteins (C-reactive protein, ferritin, interleukins, tumor necrosis factor alpha) 64 . Therefore, an inadequate protein intake, or vitamin and trace element deficiencies can lead to weakened immune responses. The risk of malnutrition in geriatric patients is increased compared to the general population. "Anorexia of aging" is a disorder characterized by a reduction of food intake and/or loss of appetite in elderly patients and it is an independent predictor of worse prognosis 65 . Some physiological age-related factors are involved in the development of anorexia in elderly patients (reduction of smell and taste, changes among hunger and satiety hormones, chronic low-grade inflammation, abnormality in gastric motility), as well as social (eg, poverty, isolation), psychological (eg, depression, dementia), medical (eg, edentulism, dysphagia, malignancy), and pharmacologic factors 65 .

COVID-19 itself can be a cause of malnutrition, due to the infectious involvement of the gastrointestinal tract with consequent malabsorption 6, 64 . It can be also responsible for sarcopenia, due to the acute inflammatory response, or as a consequence of the treatment with glucocorticoids 64 .

Damayanthi et al, conducted a systematic review on correlation between nutritional status of older patient and COVID-19 outcome, highlighting that the prevalence of malnutrition in these patients is J o u r n a l P r e -p r o o f high and negatively influences their prognosis 64 . In particular, Recinella et al., in a cross sectional study on 109 patients, showed that a moderate/severe geriatric nutritional risk index (GNRI) represented a risk factor for in-hospital death, while body mass index represented a protective factor 66 .

Two other studies found that either albumin levels (by an observational longitudinal study on 114 patients) 67 or prealbumin levels (by a retrospective cohort study on 446 patients) 68 were associated with a higher risk of transfer to ICU and all cause of death, ICU admission and mechanical ventilation respectively.

Sarcopenia also affects the respiratory and swallowing muscles. A reduction in the respiratory muscles strength hinders effective coughing 69 . Okazaki et al. reported that malnutrition, lower body trunk muscle mass and respiratory muscle weakness represent risk factors for pneumonia in elderly and malnutrition represents a risk factor for pneumonia relapse 69 .

Considering that underweight has been correlated with a higher probability of hospitalization in adult patients with viral respiratory infections from coronavirus, metapneumovirus, parainfluenza and rhinovirus 70 , and that malnutrition in the elderly can significantly influence regulatory T-cells and senescent natural killer cells, increasing the risk of infections, Lidoriki et al. speculated about a possible association between malnutrition in elderly people and COVID-19 prognosis 70 . In particular, they suggested that a combination of a respiratory infection severity score such as CURB-65, malnutrition (GNRI) and performance status (ECOG, Barthel) scores, could represent a quick and low-cost prognostic tool for COVID-19 in the elderly 70 .

Aging is also associated with ultrastructural changes in the respiratory system, including decline in the clearance of inhaled particles at level of small airways 71 , gradual reduction in the number of cilia and ciliated cells in the airways, impairment in nasal mucociliary clearance with a slower ciliary beat frequency 72 and increase in nasal cavity with a decrease in nasal resistance 73 ACE2 receptor represents the human door for SARS-COV and SARS-COV-2 entry into cells and plays a pivotal role in the pathogenesis of COVID-19 disease 74 . ACE2 receptor, a trans-membrane type I glycoprotein, is not only expressed by nasal epithelium and type II alveolar cells, but also in other tissues (myocardium, kidney, urothelial, ileum, colon, esophagus, and oral mucosa cells), thus explaining the systemic presentation of COVID-19 disease 75 . In human physiology, soluble ACE2 cleaves angiotensin II to angiotensin, limiting the detrimental effects of link angiotensin II-AT1 receptors, including vasocostriction, inflammation and thrombosis 76, 77 . After the binding of SARS-COV2 to ACE2 receptors, the spike proteins of both SARS-CoV and SARS-CoV-2 by priming a transmembrane serine protease (TMPRSS2) causes the internalization and degradation of ACE2, with down-regulation of these receptors [77] [78] . By this way, the decrease of ACE2 activity exacerbates the severity of lung injuries and inflammatory pulmonary diseases, mediated by angiotensin II 78 .

Several factors have been shown to impact on the expression of ACE2 and consequently cause the shift of ACE/ACE2 balance toward pro-inflammatory and pro-fibrotic effects mediated by ACE and the ACE-angiotensin II-AT1receptor axis [76] [77] . Aging is one of these. Recent evidence suggests that a decrease in the expression of ACE2 with age could lead to exaggerated inflammatory responses and cytokine storm 79 . Moreover, genomics and transcriptomics studies have shown an age-related reduction in the expression of ACE2 receptors in many tissues 80 .

Interestingly, different chronic disease associated with COVID-19 infection and typical of older age, such as hypertension, diabetes, cardiac disease, share a variable degree of ACE2 deficiency [75] [76] [77] . In these conditions, the consequent angiotensin II effects may result in exacerbation of hypertension, cardiac hypertrophy, maladaptive left ventricular remodeling after a myocardial infarction 75 .

Therefore, ACE2 deficiency seems to play a key role in the pathogenesis but also in the prognosis of COVID-19 infection, mainly in those subjects (i.e. elderly and with co-morbidities) with baseline ACE2 deficiency.

Among the elderly population, men have a higher risk of death from COVID-19 than women 81 . The reasons for this difference are still under investigation. One of the hypotheses concerns the reduced testosterone levels in elderly men and the related consequences on general health and the immune system 81 .

In men, testosterone levels progressively decline from the age of 30 81 . In the elderly men, low testosterone levels can be associated with various symptoms, including loss of libido, erectile dysfunction, and loss of muscle mass, among other symptoms, as well as a greater likelihood of both metabolic syndrome and cardiovascular disease. Reduced testosterone levels and the presence of such symptoms is referred to as late-onset hypogonadism (LOH) 82 and have also been associated with increased frailty 83 and mortality 84 .

In women there is a progressive reduction of testosterone levels between 20 and 40 years 85, 86 , while between 60 and 80 years they can increase in varying degrees 86, 87 . Testosterone levels in older women do not seem to play a significant role in increasing the risk of frailty 83 .

Papadopulos et al. hypothesized that reduced testosterone levels in elderly men could be associated with increased COVID-19 mortality 81 . One of the reasons may be the inhibitory role of testosterone on the immune system, by reducing the expression of inflammatory mediators (for example IL-6) and

promoting anti-inflammatory responses. High levels of IL-6 have been linked to the development of the acute respiratory distress syndrome (ARDS) in COVID-19 infections, and elderly male patients showed a higher risk to develop ARDS and death 81 .

It is also possible that SARS-Cov-2 can act directly on testicular function and testosterone levels. It has been shown in fact that Leydig cells express ACE2 and also TMPRSS2, leading testis to represent another potential target of SARS-cov-2.

J o u r n a l P r e -p r o o f Conclusions In conclusion, increasing age represents an unquestionable risk factor for poor outcomes in Covid-19

infection. Common features of older people, such as increased incidence of co-morbidities, dysregulation of immune system and malnutrition, interplay with ultrastructural changes of aged systems (mainly the respiratory one) in exacerbating inflammatory deleterious pathways triggered by SARS-COV-2 virus. In this context, ACE2 role is deserving a lot of interest as key mechanism involved in pathogenesis and evolution of disease, although data on the older subgroups are scarce and mostly theoretical. Further and more specific studies should be encouraged to better understand all these mechanisms, in order to achieve targeted approaches and, hopefully, preventive strategies in frail subjects, like the elderly.

J o u r n a l P r e -p r o o f

A Novel Coronavirus from Patients with Pneumonia in China

A pneumonia outbreak associated with a new coronavirus of probable bat origin

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

WHO Director-General's remarks at the media briefing on 2019-nCoV on 11

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Aging in COVID-19: Vulnerability, immunity and intervention

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Estimating the burden of SARS-CoV-2 in France

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

Immunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People

COVID-19 and the elderly: insights into pathogenesis and clinical decision-making

Immune System Dysfunction in the Elderly. An Acad Bras Ciênc

Alzheimer's disease, autoimmunity and inflammation. J o u r n a l P r e -p r o o f The good, the bad and the ugly

Age-related changes in lymphocyte development and function

Cell Therapy Strategies to Combat Immunosenescence

Aging and immune function: molecular mechanisms to interventions

Normal T cell homeostasis: the conversion of naive cells into memoryphenotype cells

Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling

CD28 extinction in human T cells: altered functions and the program of T-cell senescence

The Loss of Telomerase Activity in Highly Differentiated CD8+CD28−CD27− T Cells Is Associated with Decreased Akt (Ser473) Phosphorylation

Senescence of T Lymphocytes: Implications for Enhancing Human Immunity

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak

The Th17/Treg balance is disturbed during aging

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells

The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

Clinical and immunologic J o u r n a l P r e -p r o o f predictors of influenza illness among vaccinated older adults

Changes in primary lymphoid organs with aging

Human peripheral late/exhausted memory B cells express a senescent-associated secretory phenotype and preferentially utilize metabolic signaling pathways

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Immunosenescence and human vaccine immune responses

Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2

Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)

Antibody-dependent enhancement of virus infection and disease

Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

Aging immunity may exacerbate COVID-19

Garb-aging

Immune determinants of COVID-19 disease presentation and severity

Diabetes and COVID-19: A pooled analysis related to disease severity and mortality

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Comorbidity and its Impact on Patients with COVID-19

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States

The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases

Impact of comorbidities on patients with COVID-19: A large retrospective study in Zhejiang

Comorbidities and mortality in COVID-19 patients

Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

COVID-19 in people living with diabetes: An international consensus

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

Prevalence and impact of diabetes among people infected with SARS-CoV-2

High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes

Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients

Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

Patients with diabetes are at higher risk for severe illness from COVID-19

Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis

Nutritional determinants and COVID-19 outcomes of older patients with COVID-19: A systematic review

Anorexia of Aging: Assessment and Management

Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: a monocentric study

Prevalence and severity of malnutrition in hospitalized COVID-19 patients

Decreased prealbumin level is associated with increased risk for mortality in elderly hospitalized patients with COVID-19

Respiratory Muscle Weakness as a Risk Factor for Pneumonia in Older People

Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?

Long-term clearance from small airways decreases with age -PubMed

The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia

The effect of age, sex, obesity and posture on upper airway size

SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research

ACE and ACE2 in inflammation: a tale of two enzymes

Age-Dependent Changes in the Pulmonary Renin-Angiotensin System Are Associated With Severity of Lung Injury in a Model of Acute Lung Injury in Rats

The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science

Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation

Why does COVID-19 kill more elderly men than women? Is there a role for testosterone?

Late-onset hypogonadism: a concept comes of age

Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging

The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2

Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women

Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy

Androgens and women at the menopause and beyond